Andere Sprachen Xenon Pharmaceuticals Inc.

Aktien

A12ETN

CA98420N1050

XENE

Realtime-Estimate Cboe BZX Andere Börsenplätze 19:46:20 23.05.2024			% 5 Tage	% 1. Jan.
37,62 ^USD	-3,03 %		-6,49 %	-18,11 %

16.05.	Transcript : Xenon Pharmaceuticals Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:40 PM
10.05.	XENON PHARMACEUTICALS INC. : erhält Kaufen-Rating von Wedbush	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Encephalopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	21.05.
Xenon Pharmaceuticals Q1 Net Loss Narrows	09.05.
Xenon Pharmaceuticals: Q1 Earnings Snapshot	09.05.
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	09.05.
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	09.05.
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024	08.05.
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference	07.05.
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update	02.05.
Xenon Pharmaceuticals Inc. Announces Board Resignations	19.04.
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting	16.04.
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	10.04.
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	04.04.
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days	12.03.
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days	12.03.
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing	08.03.
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing	08.03.
Xenon Pharmaceuticals : Alberta Securities Commission British Columbia Securities Commission Ontario Securities Commission - Form 8-K	08.03.
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024	05.03.
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024	05.03.
Xenon Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Xenon Pharmaceuticals Inc.

Aktien

A12ETN

CA98420N1050

XENE

Andere Sprachen

Filter